Detalhe da pesquisa
1.
Real-World Outcomes of Trastuzumab Deruxtecan in Patients With HER2+ Metastatic Breast Cancer: The DE-REAL Study.
Oncologist;
29(4): 303-310, 2024 Apr 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37995313
2.
CD137+ and regulatory T cells as independent prognostic factors of survival in advanced non-oncogene addicted NSCLC patients treated with immunotherapy as first-line.
J Transl Med;
22(1): 329, 2024 Apr 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38570798
3.
Pembrolizumab-based first-line treatment for PD-L1-positive, recurrent or metastatic head and neck squamous cell carcinoma: a retrospective analysis.
BMC Cancer;
24(1): 430, 2024 Apr 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38589857
4.
An Integrated Care Approach to Improve Well-Being in Breast Cancer Patients.
Curr Oncol Rep;
26(4): 346-358, 2024 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38400984
5.
Immune-related toxicity and soluble profile in patients affected by solid tumors: a network approach.
Cancer Immunol Immunother;
72(7): 2217-2231, 2023 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36869232
6.
Systemic therapy de-escalation in advanced ovarian cancer: a new era on the horizon?
Int J Gynecol Cancer;
33(9): 1448-1457, 2023 09 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37597852
7.
Circulating CD137+ T Cell Levels Are Correlated with Response to Pembrolizumab Treatment in Advanced Head and Neck Cancer Patients.
Int J Mol Sci;
24(8)2023 Apr 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37108276
8.
Soluble PD-L1 as a Prognostic Factor for Immunotherapy Treatment in Solid Tumors: Systematic Review and Meta-Analysis.
Int J Mol Sci;
23(22)2022 Nov 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36430974
9.
The role of opioids in cancer response to immunotherapy.
J Transl Med;
19(1): 119, 2021 03 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33757546
10.
Weekly chemotherapy as first line treatment in frail head and neck cancer patients in the immunotherapy era.
J Transl Med;
19(1): 303, 2021 07 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34253248
11.
PD-1/PD-L1 checkpoint inhibitors during late stages of life: an ad-hoc analysis from a large multicenter cohort.
J Transl Med;
19(1): 270, 2021 06 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34167578
12.
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence.
J Cell Physiol;
235(11): 7900-7910, 2020 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31943171
13.
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting.
Int J Cancer;
146(7): 1917-1929, 2020 04 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31330065
14.
Agnostic evaluation of ipilimumab and nivolumab association: a metanalysis.
J Transl Med;
18(1): 446, 2020 11 25.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33239030
15.
Gut metabolomics profiling of non-small cell lung cancer (NSCLC) patients under immunotherapy treatment.
J Transl Med;
18(1): 49, 2020 02 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32014010
16.
Induction chemotherapy in nonlaryngeal human papilloma virus-negative high-risk head and neck cancer: a real-world experience.
Anticancer Drugs;
31(10): 1074-1083, 2020 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32932276
17.
The treatment paradigm of right-sided metastatic colon cancer: harboring BRAF mutation makes the difference.
Int J Colorectal Dis;
35(8): 1513-1527, 2020 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32382835
18.
Clinical and psychometric validation of the BreSAS questionnaire module for symptom assessment among breast cancer survivors.
Support Care Cancer;
28(3): 1051-1058, 2020 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31177390
19.
5-Fluorouracil degradation rate as a predictive biomarker of toxicity in breast cancer patients treated with capecitabine.
J Oncol Pharm Pract;
26(8): 1836-1842, 2020 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32131682
20.
Network Analysis of Gut Microbiome and Metabolome to Discover Microbiota-Linked Biomarkers in Patients Affected by Non-Small Cell Lung Cancer.
Int J Mol Sci;
21(22)2020 Nov 19.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33227982